Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 227-234
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.227
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.227
Figure 1 Algorithm for the screening, surveillance and management of Barrett's esophagus.
GERD: Gastroesophageal reflux disease; BMI: Body mass index. BE: Barrett's esophagus.
Figure 2 Management of high-grade dysplasia and early cancer in Barrett's esophagus.
RFA: Radiofrequency ablation; BE: Barrett's esophagus; HGD: High-grade dysplasia; EC: Early cancer; EA: Esophageal adenocarcinoma.
- Citation: Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234
- URL: https://www.wjgnet.com/2150-5349/full/v7/i2/227.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.227